Manufacturers have to exhibit that any new technology or strategy not simply meets the prevailing standards for sterility assurance but also offers tangible Positive aspects in terms of effectiveness, trustworthiness, or product or service security. As these new technologies emerge, the WHO emphasizes the importance of a radical possibility